THE JOHNS HOPKINS UNIVERSITY

A modified DASH diet tailored for diabetes (DASH4D) significantly reduced systolic blood pressure by 4.6 mm Hg and diastolic pressure by 2.3 mm Hg in type 2 diabetes patients.

New research published in Nature Communications reveals that immune checkpoint inhibitors (ICIs) demonstrate comparable efficacy in cancer patients regardless of age, with some older patients showing even better outcomes.

Recent research reveals that higher cardiorespiratory fitness is associated with better cognitive performance across multiple domains in older adults, regardless of genetic risk factors for Alzheimer's disease.

Johns Hopkins reports approximately 200 patients now receiving regular omalizumab injections for food allergies, with treatment particularly beneficial for those with multiple allergies or hard-to-avoid foods.

Johns Hopkins researchers are leading ARBOR-Telehealth, an innovative NIH Collaboratory trial investigating telehealth physical therapy solutions for rural patients with low back pain.

Researchers have found that anti-VEGF treatments for wet age-related macular degeneration (AMD) may paradoxically increase levels of ANGPTL4, a protein that promotes abnormal blood vessel growth.

Four major NCI-designated cancer centers, including Dana-Farber and Memorial Sloan Kettering, have united to form the Cancer AI Alliance (CAIA) with $40 million in funding from tech giants AWS, Microsoft, NVIDIA, and Deloitte.

• Prurigo nodularis and atopic dermatitis share underlying mechanisms, particularly related to chronic itch, with similar cytokines conserved between the diseases. • Shared pathophysiology has led to the approval of dupilumab for both prurigo nodularis and atopic dermatitis, highlighting the importance of understanding these common pathways. • Novel targeted therapeutics, including nonsteroidal topical therapies like PDE4-inhibitors and JAK inhibitors, are changing the treatment landscape for atopic dermatitis. • Emerging biologics targeting IL-4 receptor alpha, IL-13, and IL-31 show promise in managing chronic itch in both prurigo nodularis and atopic dermatitis.

A recent study published in the New England Journal of Medicine reveals that kidney transplants from HIV-positive donors are non-inferior to those from HIV-negative donors in HIV-positive recipients.

Researchers developed novel PBAE nanoparticles for efficient mRNA delivery to lung cells via systemic administration, showing promise for treating genetic lung diseases.